Moderna: Flu Vaccine Progress Is Only Part Of The Story (NASDAQ:MRNA)
· seekingalpha.com
Moderna received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. Read more on MRNA stock here.
Moderna, Inc. ( MRNA ) has been a strong performer in 2026 with the name up ~117% year-to-date, although H2'26 catalysts could enhance or undo that performance....